• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 32 of 38
A Pfizer sign hangs on the outside of their headquarters in New York City.
Finance
ICU Medical Acquires Pfizer’s Infusion Therapy Business
By ReutersOctober 6, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Health
Pfizer Has Abandoned Its Plan to Split Into Two Companies
By ReutersSeptember 26, 2016
US-VOTE-DEMOCRATS-CLINTON
Health
What We Still Don’t Know About Clinton’s and Trump’s Health
By Sy MukherjeeSeptember 14, 2016
CNBC Events
Health
Pfizer’s CEO Just Slammed Hillary Clinton’s Plan to Lower Drug Prices
By Sy MukherjeeSeptember 9, 2016
CNBC Events
Health
Allergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
The Davos World Economic Forum 2015
Health
Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
Pfizer Scientists In Lab In Cambridge, Mass.
Finance
Pfizer’s Medivation Deal May Not Be Enough
By Jen WiecznerAugust 22, 2016
Pfizer Is Buying Cancer Drug Maker Medivation
Health
Pfizer Is Buying Cancer Drug Maker Medivation
By ReutersAugust 22, 2016
Pfizer In Merger Talks With Allergan PLC
Finance
Pfizer ‘In Advanced Talks’ to Acquire Medivation for About $14 Billion
By Reuters and Michelle TohAugust 21, 2016
90306508
Finance
Failed Pfizer-Allergan Merger Had Hedge Funds Scrambling in Q2
By Reuters and Aaron TaskAugust 15, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance
Big Business Groups Just Sued the Government for Blocking the Pfizer-Allergan Merger
By Jen WiecznerAugust 4, 2016
Pfizer Inc. Headquarters As They Agree To Combine With Allergan Plc In $160 Billion Deal
Finance
Pfizer Breakup May Depend on Trump or Clinton Winning the Election
By Jen WiecznerAugust 2, 2016
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Health
Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals
By Sy MukherjeeAugust 2, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health
These Two New Areas Were Behind Pfizer’s Impressive Second Quarter Profits
By ReutersAugust 2, 2016
Trading On The Floor Of The NYSE As Dollar And Stocks Slide And Bonds Rally With Gold After Jobs Data
Health
Pfizer Just Spent about $645 Million to Buy This Gene Therapy Company
By ReutersAugust 1, 2016
1...
  • 30
  • 31
  • 32
  • 33
  • 34
...38
Most Popular
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Success
Despite a $150 million net worth, Quentin Tarantino refuses to give a ‘penny’ of his fortune to his mother: ‘No house, no Cadillac’placeholder alt text
By Orianna Rosa RoyleOctober 28, 2026
Economy
For the first time since 1992, a Fed governor and president dissented together, as Kevin Warsh says the 'monetary medicine' is starting to workplaceholder alt text
By Catherina GioinoOctober 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.